Effect of Methyl Jasmonate Elicitation on Triterpene Production and Evaluation of Cytotoxic Activity of Mycelial Culture Extracts of Ganoderma applanatum (Pers.) Pat.

Abiotic elicitation, a well-known strategy in mushroom biotechnology, promotes increased accumulation of secondary metabolites in mycelial cultures. The study aimed the effects of methyl jasmonate (MeJA) on the production of triterpenes in submerged cultures of Ganoderma applanatum. Further, the study evaluated the cytotoxic activity of the extract corresponding to the optimal elicitation variant in selected human cancer cell lines as well as the selectivity against normal cells. MeJA was added on days 1, 4, 6, and 8 in the 10-day growth cycle at concentrations of 10, 50, 100, 150, and 200 µM MeJA. The HPLC-DAD was used to analyze the triterpenes. The cytotoxic activity was tested using the MTTFc assay in grouped panels of skin, prostate, and gastrointestinal cancer cells. The results of the quantitative analyses confirmed the stimulating effect of MeJA on the production of ganoderic acid A and ganoderic acid C. The greatest increase in total triterpenes was found on day 6 of the culture cycle compared to the control group—with the concentration of MeJA—150 µM. Compared to the control samples, mycelial culture extract after the most productive elicitation variant showed significant cytotoxic activity against prostate cancer cells and moderate effects on melanoma cells. Ganoderma applanatum mycelial cultures can be proposed as a model to study the dynamics of the accumulation of compounds with therapeutic values through abiotic elicitation.

[1]  Zhengzheng Liao,et al.  Nor-triterpenoids from the fruiting bodies of Ganoderma lucidum and their inhibitory activity against FAAH , 2022, Natural product research.

[2]  G. Zengin,et al.  Bioactivity and Mycochemical Profile of Extracts from Mycelial Cultures of Ganoderma spp. , 2022, Molecules.

[3]  Liman Zhou,et al.  Triterpenoids and meroterpenoids with α-glucosidase inhibitory activities from the fruiting bodies of Ganoderma australe. , 2021, Bioorganic chemistry.

[4]  Zhicheng Liu,et al.  A new anti-tumor cytotoxic triterpene from Ganoderma lucidum , 2021, Natural product research.

[5]  P. Paśko,et al.  Bioactivity and cytotoxicity of different species of pitaya fruits – A comparative study with advanced chemometric analysis , 2021 .

[6]  B. Muszyńska,et al.  Mycelial culture extracts of selected wood-decay mushrooms as a source of skin-protecting factors , 2021, Biotechnology Letters.

[7]  S. Mohan,et al.  Ganoderma lucidum put forth anti-tumor activity against PC-3 prostate cancer cells via inhibition of Jak-1/STAT-3 activity , 2020, Saudi journal of biological sciences.

[8]  Wróbel-Biedrawa Dagmara,et al.  Anti-melanoma potential of two benzoquinone homologues embelin and rapanone - a comparative in vitro study. , 2020, Toxicology in vitro : an international journal published in association with BIBRA.

[9]  Junbo Xia,et al.  Ganoderic Acid A improves high fat diet-induced obesity, lipid accumulation and insulin sensitivity through regulating SREBP pathway. , 2018, Chemico-biological interactions.

[10]  I. El-Garawani,et al.  Ganoderma applanatum secondary metabolites induced apoptosis through different pathways: In vivo and in vitro anticancer studies. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[11]  M. A. Khan,et al.  Production of biomass and useful compounds through elicitation in adventitious root cultures of Fagonia indica , 2017 .

[12]  Xutong Wang,et al.  Methyl jasmonate induces triterpenoid biosynthesis in Inonotus baumii , 2017 .

[13]  Xiangqun Xu,et al.  Stimulated production of triterpenoids of Inonotus obliquus using methyl jasmonate and fatty acids , 2016 .

[14]  Sabulal Baby,et al.  Secondary metabolites from Ganoderma. , 2015, Phytochemistry.

[15]  I. Ferreira,et al.  Bioactivity of phenolic acids: metabolites versus parent compounds , 2015 .

[16]  Zhu-Liang Yang,et al.  Applanatumin A, a new dimeric meroterpenoid from Ganoderma applanatum that displays potent antifibrotic activity. , 2015, Organic letters.

[17]  C. Schmidt-Dannert Biosynthesis of terpenoid natural products in fungi. , 2015, Advances in biochemical engineering/biotechnology.

[18]  J. Turło The biotechnology of higher fungi - current state and perspectives , 2014 .

[19]  P. Lei,et al.  Review on anti-tumor effect of triterpene acid compounds. , 2014, Journal of cancer research and therapeutics.

[20]  M. Kandefer-Szerszeń,et al.  Exopolysaccharide from Ganoderma applanatum as a Promising Bioactive Compound with Cytostatic and Antibacterial Properties , 2014, BioMed research international.

[21]  Xiaochi Ma,et al.  Structural characterization of minor metabolites and pharmacokinetics of ganoderic acid C2 in rat plasma by HPLC coupled with electrospray ionization tandem mass spectrometry. , 2013, Journal of pharmaceutical and biomedical analysis.

[22]  Axel A. Brakhage,et al.  Regulation of fungal secondary metabolism , 2012, Nature Reviews Microbiology.

[23]  M. Recio,et al.  Lanostanoids from fungi: a group of potential anticancer compounds. , 2012, Journal of natural products.

[24]  Chunping Xu,et al.  Optimization for betulin production from mycelial culture of Inonotus obliquus by orthogonal design and evaluation of its antioxidant activity , 2012 .

[25]  J. Zhong,et al.  Cytotoxic and pro-apoptotic effects of novel ganoderic acid derivatives on human cervical cancer cells in vitro. , 2012, European journal of pharmacology.

[26]  Akpera T. Manasseh,et al.  Phytochemical properties of Ganoderma applanatum as potential agents in the application of nanotechnology in modern day medical practice , 2012 .

[27]  Z. Qin,et al.  Ganoderma applanatum terpenes protect mouse liver against benzo(α)pyren-induced oxidative stress and inflammation. , 2011, Environmental toxicology and pharmacology.

[28]  Jie-Qiong Ma,et al.  Cellular and molecular mechanisms of the Ganoderma applanatum extracts induces apoptosis on SGC‐7901 gastric cancer cells , 2011, Cell biochemistry and function.

[29]  X. Di,et al.  Sensitive and selective liquid chromatography-tandem mass spectrometry method for the determination of five ganoderic acids in Ganoderma lucidum and its related species. , 2011, Journal of pharmaceutical and biomedical analysis.

[30]  Axel A Brakhage,et al.  Fungal secondary metabolites - strategies to activate silent gene clusters. , 2011, Fungal genetics and biology : FG & B.

[31]  E. Jovin,et al.  Medicinal and edible lignicolous fungi as natural sources of antioxidative and antibacterial agents , 2010, Phytotherapy research : PTR.

[32]  D. Guo,et al.  Cytotoxic triterpenoids from Ganoderma lucidum. , 2010, Phytochemistry.

[33]  L. Qin,et al.  Methyl jasmonate induces ganoderic acid biosynthesis in the basidiomycetous fungus Ganoderma lucidum. , 2010, Bioresource technology.

[34]  Wei Zhao,et al.  Biotechnological production and application of ganoderic acids , 2010, Applied Microbiology and Biotechnology.

[35]  R. Kondo,et al.  Inhibition of aldose reductase in vitro by constituents of Ganoderma lucidum. , 2010, Planta medica.

[36]  B. Howlett,et al.  Secondary metabolism: regulation and role in fungal biology. , 2008, Current opinion in microbiology.

[37]  Eunhye Kim,et al.  Phenolic compound concentration and antioxidant activities of edible and medicinal mushrooms from Korea. , 2008, Journal of agricultural and food chemistry.

[38]  C. Hung,et al.  Antiinflammatory triterpenoids and steroids from Ganoderma lucidum and G. tsugae. , 2008, Phytochemistry.

[39]  Yu-sun Jung,et al.  Hypoglycemic effects of Ganoderma applanatum and Collybia confluens exo‐polymers in streptozotocin‐induced diabetic rats , 2007, Phytotherapy research : PTR.

[40]  D. Wei,et al.  Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. , 2006, Life sciences.

[41]  R. Paterson,et al.  Ganoderma - a therapeutic fungal biofactory. , 2006, Phytochemistry.

[42]  N. Rowan,et al.  Medicinal Mushrooms and Cancer Therapy: translating a traditional practice into Western medicine , 2006, Perspectives in biology and medicine.

[43]  K. Acharya,et al.  Antioxidant and nitric oxide synthase activation properties of Ganoderma applanatum. , 2005, Indian journal of experimental biology.

[44]  H. Wichers,et al.  Antiinflammatory and Immunomodulating Properties of Fungal Metabolites , 2005, Mediators of inflammation.

[45]  T. Mizuno The Extraction and Development of Antitumor-Active Polysaccharides from Medicinal Mushrooms in Japan (Review) , 1999 .

[46]  I. Miura,et al.  Structures of Ganoderic Acid A and B, Two New Lanostane Type Bitter Triterpenes from Ganoderma lucidum (FR.) KARST. , 1982 .